US Edition
News from GlobalData
We’ve assigned a media bias rating of unknown to GlobalData. You can read more about our methodology here.
We’ve assigned a rating of Unknown factuality to GlobalData. You can read more about how we’ve determined GlobalData’s credibility and reliability as a news source here: https://ground.news/rating-system.
Media Bias Ratings
Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top GlobalData News
UK Economy · EnglandThousands of jobs are at risk after discount high street chain Poundland was sold - with dozens of shops expected to shut. Poundland has been sold for a headline figure of €1 to investment firm and former Laura Ashley owners Gordon Brothers, confirming Sky News reporting.See the Story
Thousands of Poundland jobs at risk as shops to close after company sold
85% Center coverage: 61 sources
Merck · United StatesThe Food and Drug Administration has approved a new drug from Merck designed to protect infants from respiratory syncytial virus, or RSV, a common but potentially serious seasonal illness.The drug, Enflonsia, is a long-acting monoclonal antibody intended to prevent RSV-related lower respiratory tract disease in newborns and infants entering their first RSV season.RSV is a leading cause of hospitalization among infants in the United States, espec…See the Story
FDA Approves Merck’s Enflonsia to Prevent RSV in Infants
51% Center coverage: 37 sources
